Pyridine Acetamide

Pyridine Acetamide

SCHEMBL2791176

NC(=O)Cc1ccccn1.NC(=O)Cc1ccncc1

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.48
RAB9A P51151 2/20 0.45
NPC1 O15118 1/20 0.45
CYP19A1 P11511 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
IDO1 P14902 1/20 0.43
PARP10 Q53GL7 1/20 0.43
ALDH1A1 P00352 2/20 0.43
GAA P10253 1/20 0.43
MAPT P10636 1/20 0.43
CA2 P00918 2/20 0.42
KDM4E B2RXH2 1/20 0.42
CA1 P00915 1/20 0.42
CA5A P35218 1/20 0.42
CA7 P43166 1/20 0.42
CA5B Q9Y2D0 1/20 0.42
PTPRA P18433 1/20 0.41
LMNA P02545 1/20 0.41
HRH1 P35367 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyridine Acetamide SCHEMBL11215815 0.91 LOXL2 (0.48) POLBRAB9ANPC1SMN1; SMN2IDO1
Pyridine Acetamide SCHEMBL29431271 0.88 RAB9A (0.54) POLBRAB9ANPC1SMN1; SMN2IDO1
Pyridine Acetamide SCHEMBL176893 0.88 RAB9A (0.54) POLBRAB9ANPC1SMN1; SMN2IDO1
Pyridine Acetamide SCHEMBL3723681 0.86 RAB9A (0.53) POLBRAB9ANPC1SMN1; SMN2IDO1
Pyridine Acetamide SCHEMBL7432558 0.86 RAB9A (0.53) POLBRAB9ANPC1SMN1; SMN2IDO1
Pyridine Acetamide SCHEMBL5709841 0.86 RAB9A (0.53) POLBRAB9ANPC1SMN1; SMN2IDO1
SCHEMBL1178369 0.82 CA2 (0.58) RAB9ACYP19A1SMN1; SMN2ALDH1A1GAA
Hydrochloric Acid SCHEMBL2673007 0.80 CA2 (0.56) RAB9ACYP19A1SMN1; SMN2ALDH1A1GAA
Pyridine Acetamide SCHEMBL10410418 0.80 RAB9A (0.47) POLBRAB9ANPC1SMN1; SMN2IDO1
Pyridine SCHEMBL639564 0.79 GAA (0.50) POLBCYP19A1ALDH1A1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10092490-B2 Method for straightening keratinous fibres using heating means and an amide L'OREAL (FR) 2018-10-09 US disclosed
US-20100163070-A1 METHOD FOR STRAIGHTENING KERATINOUS FIBRES USING HEATING MEANS AND AN AMIDE L'OREAL S.A. (FR) 2010-07-01 US disclosed
US-20100028280-A1 PROCESS FOR STRAIGHTENING KERATIN FIBRES WITH A HEATING MEANS AND DENATURING AGENTS L'OREAL S.A. (FR) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100028280-A1 PROCESS FOR STRAIGHTENING KERATIN FIBRES WITH A HEATING MEANS AND DENATURING AGENTS KRT18, KRTCAP2, TUBB4A POLB 349/4885RAB9A 4079/4885NPC1 4391/4885
US-10092490-B2 Method for straightening keratinous fibres using heating means and an amide KRT18, TUBB3, KIF5C POLB 476/4885RAB9A 4578/4885NPC1 3618/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.